Objective:

To enhance the surgical evaluation and treatment process for patients with drug-resistant epilepsy through advanced technologies.

Approach:

• Robotic sEEG: Utilization of robotic stereo EEG (sEEG) to improve localization of seizure origins.
• Responsive Neurostimulation: Increasing application of responsive neurostimulation (RNS) for patients ineligible for resection or ablation.
• Multidisciplinary Pathway: Implementation of a coordinated multidisciplinary review to optimize the surgical pathway for epilepsy treatment.

Key Findings:

• Timely referral for surgical evaluation can significantly change the care trajectory for patients with drug-resistant epilepsy.
• Robotic sEEG enhances precision in electrode placement and reduces operative time.
• Comprehensive evaluation can identify candidates for various treatment options, including resection, laser ablation, and neuromodulation.

Interpretation:

Identifying seizure origins is essential for determining suitable treatment pathways, which may include surgical options or ongoing medical management.

Limitations:

• The article lacks specific data on patient outcomes or success rates associated with the new interventions.
• There is no comparative analysis with other epilepsy centers provided.

Conclusion:

Baptist Health Miami Neuroscience Institute is advancing its approach to drug-resistant epilepsy through innovative technologies and collaborative care.